10x Genomics (NASDAQ:TXG – Get Free Report) will post its quarterly earnings results after the market closes on Thursday, August 3rd. Analysts expect 10x Genomics to post earnings of ($0.39) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link. 10x Genomics (NASDAQ:TXG – […]
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $60.14 and last traded at $59.94, with a volume of 410895 shares changing hands. The stock had previously closed at $58.41. Wall Street Analyst Weigh In Several analysts […]
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report) saw a significant drop in short interest in June. As of June 30th, there was short interest totalling 48,120,000 shares, a drop of 19.5% from the June 15th total of 59,800,000 shares. Based on an average trading volume of 10,440,000 shares, the short-interest ratio is currently 4.6 […]
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Rating) Director Hannah Mamuszka bought 65,789 shares of the stock in a transaction on Tuesday, June 13th. The shares were acquired at an average cost of $0.76 per share, for a total transaction of $49,999.64. Following the purchase, the director now owns 65,789 shares in the company, valued at […]
10x Genomics, Inc. (NASDAQ:TXG – Get Rating) Director John R. Stuelpnagel sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $54.89, for a total transaction of $548,900.00. Following the completion of the sale, the director now directly owns 333,736 […]